Read more

March 17, 2021
1 min read
Save

Delayed kidney graft function after heart-kidney transplant linked with worse outcomes

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients who had delayed kidney graft function after a simultaneous heart and kidney transplant had worse outcomes than those who did not have delayed kidney graft function, according to published findings.

“Although there are multiple studies of [delayed graft function] DGF and its impact in kidney-only transplant recipients, there are limited data about the risk and outcomes for kidney DGF (K-DGF) in multi-organ transplant recipients,” Sandesh Parajuli, MD, and colleagues wrote.

The retrospective analysis used Organ Procurement and Transplantation Network/United Network for Organ Sharing data of 1,161 patients (mean age, 53.89 years; received pre-transplant dialysis, 40.2%) who had a heart and kidney transplant performed within a 48-hour period between 1998 and 2018. Among patients, 311 (27%) had kidney delayed graft function and 850 did not. Researchers compared outcomes between patients who did and those who did not have kidney delayed graft function after a simultaneous heart and kidney transplant.

Investigators found treatment with dialysis before the transplant “was significantly associated with” developing kidney delayed graft function (OR = 3.95). These patients had a higher risk for mortality (hazard ratio = 1.99;) and death censored kidney graft failure (HR = 3.51) compared with those who did not have kidney delayed graft function, the researchers wrote.

“Similar to kidney-only recipients, [kidney delayed graft function] K-DGF in [simultaneous heart and kidney] SHK recipients is associated with worse outcomes,” researchers wrote. “Careful matching of recipients and donors, as well as peri-operative management, may help reduce the risk of K-DGF and the associated detrimental effects.”